CWG
EIGR

C WorldWide Group’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

C WorldWide Group’s Portfolio EIGR Stock Details EIGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-667
Closed -$5.68M – 140
2015
Q1 		$5.68M Buy
+667
New +$5.83M 0.08% 53

Other funds holding EIGR

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

C WorldWide Group's EIGR Position: Q2 2015 in Review

C WorldWide Group sold out of Eiger BioPharmaceuticals, Inc. (EIGR) in Q2 2015, closing a stake of 667 shares — an estimated $5.68M sold.

C WorldWide Group first reported a position in EIGR in Q1 2015 and held it in 1 quarter. The position peaked at $5.68M in Q1 2015. 44 funds tracked by Wall St. Rank hold EIGR as of Q2 2015.

  • C WorldWide Group reported no remaining Eiger BioPharmaceuticals, Inc. position as of Q2 2015 after selling out during the quarter.
  • C WorldWide Group sold 667 Eiger BioPharmaceuticals, Inc. shares in Q2 2015, an estimated $5.68M.
  • C WorldWide Group first reported a position in Eiger BioPharmaceuticals, Inc. in Q1 2015 and held it in 1 quarter.
  • C WorldWide Group's Eiger BioPharmaceuticals, Inc. position peaked at $5.68M in Q1 2015.
  • 44 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q2 2015.

Based on C WorldWide Group's 13F filing for Q2 2015, filed 21 Jul 2015.